Ohio State University Comprehensive Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Employees: -

Market Cap: -

Website: http://www.cancer.osu.edu

Clinical Trials

Addiction and Behavior Related to Menthol Cigarette Substitutes

Not Applicable

Completed

Conditions: Smoking (Tobacco) Addiction

Interventions: Behavioral: Menthol cigarettes substitutes
Behavioral: Usual brand menthol cigarettes and substitutes
Behavioral: Menthol cigarettes substitutes and menthol cigarettes

First Posted Date: 2021-04-14

Last Posted Date: 2024-02-09

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 120

Registration Number: NCT04844762

Locations: 🇺🇸
The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Osimertinib and Tegavivint as First-Line Therapy for the Treatment of Metastatic EGFR-Mutant Non-small Cell Lung Cancer

Phase 1

Recruiting

Conditions: Metastatic Lung Non-Small Cell Carcinoma
Stage IVA Lung Cancer AJCC v8
Stage IV Lung Cancer AJCC v8
Stage IVB Lung Cancer AJCC v8

Interventions: Drug: Osimertinib
Drug: Tegavivint

First Posted Date: 2021-03-03

Last Posted Date: 2023-12-11

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 18

Registration Number: NCT04780568

Locations: 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Combining Immunotherapy Salvage Surgery & IORT Tx Persistent/Recurrent Head & Neck Cancer

Phase 1

Recruiting

Conditions: Recurrent Laryngeal Squamous Cell Carcinoma
Head and Neck Carcinoma of Unknown Primary
Locally Recurrent Head and Neck Squamous Cell Carcinoma
Recurrent Oral Cavity Squamous Cell Carcinoma
Recurrent Pharyngeal Squamous Cell Carcinoma
Resectable Head and Neck Squamous Cell Carcinoma

Interventions: Radiation: External Beam Radiation Therapy
Radiation: Intraoperative Radiation Therapy
Biological: Pembrolizumab
Other: Quality-of-Life Assessment
Procedure: Salvage Surgery

First Posted Date: 2021-02-15

Last Posted Date: 2024-05-21

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 45

Registration Number: NCT04754321

Locations: 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Group-Mediated Cognitive Behavioral Resistance Exercise Intervention in Head and Neck Cancer Patients Undergoing Chemoradiation Treatment

Not Applicable

Active, not recruiting

Conditions: Locally Advanced Head and Neck Squamous Cell Carcinoma

Interventions: Other: Counseling
Behavioral: Dietary Counseling and Surveillance
Other: Quality-of-Life Assessment
Other: Questionnaire Administration
Other: Resistance Training

First Posted Date: 2021-02-02

Last Posted Date: 2024-05-16

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 20

Registration Number: NCT04733495

Locations: 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Changes in Pelvic Health, Sexual Function, and Quality of Life in Women With Pelvic Cancer Undergoing Radiation Therapy

Active, not recruiting

Conditions: Cervical Carcinoma
Vulvar Carcinoma
Malignant Pelvic Neoplasm
Vaginal Carcinoma
Anal Carcinoma
Endometrial Carcinoma
Rectal Carcinoma

Interventions: Procedure: Pelvic Examination
Other: Survey

First Posted Date: 2021-01-19

Last Posted Date: 2024-03-08

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 89

Registration Number: NCT04713618

Locations: 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Embedded Palliative Care in Managing Symptoms in Participants With Recurrent Stage III-IV Thoracic Malignancies and Their Caregivers

Not Applicable

Completed

Conditions: Stage IVB Lung Cancer AJCC v8
Caregiver
Malignant Pleural Neoplasm
Metastatic Thymic Carcinoma
Stage IIIA Lung Cancer AJCC v8
Stage IIIB Lung Cancer AJCC v8
Stage IVA Lung Cancer AJCC v8
Recurrent Lung Carcinoma
Recurrent Thymic Carcinoma
Stage III Lung Cancer AJCC v8

Interventions: Other: Palliative Therapy
Other: Questionnaire Administration

First Posted Date: 2020-12-10

Last Posted Date: 2023-10-26

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 68

Registration Number: NCT04662645

Locations: 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

The RIOT Trial: Re-Defining Frailty and Improving Outcomes With Prehabilitation for Pancreatic, Liver, or Gastric Cancer

Not Applicable

Active, not recruiting

Conditions: Adult Liver Carcinoma
Malignant Solid Neoplasm
Pancreatic Carcinoma
Gastric Carcinoma

Interventions: Other: Best Practice
Behavioral: Exercise Intervention
Procedure: Physical Therapy
Other: Questionnaire Administration

First Posted Date: 2020-10-26

Last Posted Date: 2024-02-12

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 66

Registration Number: NCT04602026

Locations: 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Bright White Light Therapy for the Improvement of Sleep, Fatigue, Distress, Depression, and Anxiety in Hospitalized Leukemia Patients

Not Applicable

Completed

Conditions: Recurrent Leukemia
Acute Leukemia
Refractory Leukemia

Interventions: Other: Best Practice
Other: Survey Administration
Procedure: Bright White Light Therapy

First Posted Date: 2020-10-22

Last Posted Date: 2023-04-07

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 74

Registration Number: NCT04597086

Locations: 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

A Storage Facility for Tissues Obtained From Patients With Malignant Melanoma

Recruiting

Conditions: Melanoma

Interventions: Procedure: Biospecimen Collection

First Posted Date: 2020-09-28

Last Posted Date: 2024-03-08

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 1000

Registration Number: NCT04567706

Locations: 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia

Phase 2

Active, not recruiting

Conditions: Sars-CoV2
Covid-19
Pneumonia

Interventions: Radiation: Low dose radiation 35 cGy
Radiation: High dose radiation 100 cGy

First Posted Date: 2020-07-10

Last Posted Date: 2023-12-01

Lead Sponsor: Ohio State University Comprehensive Cancer Center

Target Recruit Count: 37

Registration Number: NCT04466683

Locations: 🇺🇸
Lowell General Hospital Cancer Center, Lowell, Massachusetts, United States
🇺🇸
Miami Cancer Institute, Miami, Florida, United States
🇺🇸
Loyola University Chicago, Maywood, Illinois, United States

and more 4 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy